Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127975201 | 12797520 | 1 | I | 20160128 | 20160919 | 20160930 | 20160930 | EXP | CN-BAXTER-2016BAX048909 | BAXTER | 66.00 | YR | M | Y | 142.00000 | KG | 20160929 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127975201 | 12797520 | 1 | SS | 20% MANNITOL INJECTION | MANNITOL | 1 | Intravenous drip | Y | S1511001,S1511001 | 0 | 125 | ML | INJECTION | QD | |||||
| 127975201 | 12797520 | 2 | SS | 20% MANNITOL INJECTION | MANNITOL | 1 | Intravenous drip | DOSE REDUCED (AT A SLOWER RATE) | Y | S1511001,S1511001 | 0 | INJECTION | QD | ||||||
| 127975201 | 12797520 | 3 | SS | 20% MANNITOL INJECTION | MANNITOL | 1 | Y | S1511001,S1511001 | 0 | ||||||||||
| 127975201 | 12797520 | 4 | PS | 5% GLUCOSE INJECTION | DEXTROSE | 1 | Intravenous drip | U | 20179 | 250 | ML | SOLUTION FOR INFUSION | QD | ||||||
| 127975201 | 12797520 | 5 | SS | 5% GLUCOSE INJECTION | DEXTROSE | 1 | U | 20179 | |||||||||||
| 127975201 | 12797520 | 6 | SS | 5% GLUCOSE INJECTION | DEXTROSE | 1 | U | 20179 | |||||||||||
| 127975201 | 12797520 | 7 | SS | VITAMIN C | ASCORBIC ACID | 1 | Intravenous drip | U | 0 | 2 | G | QD | |||||||
| 127975201 | 12797520 | 8 | SS | VITAMIN C | ASCORBIC ACID | 1 | U | 0 | |||||||||||
| 127975201 | 12797520 | 9 | SS | VITAMIN C | ASCORBIC ACID | 1 | U | 0 | |||||||||||
| 127975201 | 12797520 | 10 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Intravenous drip | U | 0 | .5 | G | QD | |||||||
| 127975201 | 12797520 | 11 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | U | 0 | |||||||||||
| 127975201 | 12797520 | 12 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127975201 | 12797520 | 1 | Dizziness |
| 127975201 | 12797520 | 2 | Vertigo |
| 127975201 | 12797520 | 3 | Upper respiratory tract infection |
| 127975201 | 12797520 | 4 | Dizziness |
| 127975201 | 12797520 | 5 | Vertigo |
| 127975201 | 12797520 | 6 | Upper respiratory tract infection |
| 127975201 | 12797520 | 7 | Dizziness |
| 127975201 | 12797520 | 8 | Vertigo |
| 127975201 | 12797520 | 9 | Upper respiratory tract infection |
| 127975201 | 12797520 | 10 | Vertigo |
| 127975201 | 12797520 | 11 | Upper respiratory tract infection |
| 127975201 | 12797520 | 12 | Dizziness |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127975201 | 12797520 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127975201 | 12797520 | Chills | |
| 127975201 | 12797520 | Feeling cold | |
| 127975201 | 12797520 | Poor quality drug administered | |
| 127975201 | 12797520 | Product odour abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127975201 | 12797520 | 1 | 20160128 | 20160128 | 0 | |
| 127975201 | 12797520 | 2 | 20160128 | 20160128 | 0 |